Markets & Regulations

(Panuwat Sikham/iStock via Getty Images Plus)

Tech Innovations: April 2021

By Jenni Spinner

This month’s roundup of new equipment, materials, digital solutions and other news includes items from Lonza, Waters, Eversana, Clinical Ink, and more.

(alphaspirit/iStock via Getty Images Plus)

IQVIA completes acquisition of Q2 Diagnostics

By Jenni Spinner

The clinical research tech specialists, which had held 60% of Q2 Diagnostics, will now wholly own the comprehensive clinical laboratory services company.

(OstapenkoOlena/iStock via Getty Images Plus)

People on the Move: April 2021

By Jenni Spinner

This month’s hires, promotions, acquisitions and other notable news includes Ajinomoto, Medable, Charles River, Immunai, AstraZeneca and other top firms.

© GettyImages/Pheelings Media

FDA rebuff for Keytruda in breast cancer indication

By Jane Byrne

A couple of new developments to report in relation to Merck, known as MSD outside the US and Canada: the first being the rejection by the US FDA of the company’s application to use its anti-PD-1 therapy, Keytruda, in certain breast cancer patients.

Follow us


View more